Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.

Autor: Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P, Gonias, Sara, Goldsby, Robert, Matthay, Katherine K, Hawkins, Randall, Price, David, Huberty, John, Damon, Lloyd, Linker, Charles, Sznewajs, Aimee
Zdroj: Journal of Clinical Oncology; 9/1/2009, Vol. 27 Issue 25, p4162-4168, 7p
Databáze: Supplemental Index